Home › Funds › AltraVue Capital, LLC › AGYS
AltraVue Capital, LLC position in AGYS
AGILYSYS INC · Technology
AltraVue Capital, LLC reported holding 550,767 shares of AGYS (AGILYSYS INC) in its Q3 2026 13F filing — a position valued at US$53.5M, representing 4.63% of its reported portfolio and ranking #6 among its reported holdings. AltraVue Capital, LLC has disclosed AGYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How AltraVue Capital, LLC's AGYS position evolved
AltraVue Capital, LLC first disclosed a stake in AGYS in Q3 2023 at 389,667 shares (US$25.8M). The position peaked in Q2 2026 at 552,557 shares, worth US$57.7M. Across 13 filings, AltraVue Capital, LLC increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 550,767 shares valued at US$53.5M. Notable position changes include a 36% increase in Q2 2026 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 389.67K | $25.78M | New |
| Q4 2023 | 378.66K | $32.12M | Reduce |
| Q1 2024 | 372.00K | $31.34M | Reduce |
| Q2 2024 | 367.32K | $38.25M | Reduce |
| Q3 2024 | 365.81K | $39.86M | Hold |
| Q4 2024 | 365.81K | $48.18M | Hold |
| Q1 2025 | 332.31K | $24.11M | Reduce |
| Q2 2025 | 342.94K | $39.31M | Add |
| Q3 2025 | 350.04K | $36.84M | Add |
| Q4 2025 | 348.78K | $41.45M | Hold |
| Q1 2026 | 405.97K | $28.88M | Add |
| Q2 2026 | 552.56K | $57.74M | Add |
| Q3 2026 | 550.77K | $53.47M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AGYS and 13F data
AGYS (AGILYSYS INC) is a Technology company. 34 other funds we track also report a position in AGYS — the largest reported positions include MAK CAPITAL ONE LLC (US$124.6M), GENEVA CAPITAL MANAGEMENT LLC (US$45.2M), EMERALD ADVISERS, LLC (US$41.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AGYS
- MAK CAPITAL ONE LLC 1.19M sh · $124.64M · Q2 2026
- GENEVA CAPITAL MANAGEMENT LLC 465.18K sh · $45.16M · Q3 2026
- EMERALD ADVISERS, LLC 431.44K sh · $41.88M · Q3 2026
- Conestoga Capital Advisors, LLC 385.29K sh · $37.40M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 354.80K sh · $34.44M · Q3 2026
More on AltraVue Capital, LLC
FAQ
How long has AltraVue Capital, LLC held AGYS?
AltraVue Capital, LLC has disclosed AGYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is AltraVue Capital, LLC's current position in AGYS?
As of Q3 2026, AltraVue Capital, LLC holds 550.77K shares of AGYS (AGILYSYS INC), valued at $53.47M, representing 4.63% of its reported portfolio and ranking #6.
Has AltraVue Capital, LLC been buying or selling AGYS?
In the latest 13F filing (Q3 2026), AltraVue Capital, LLC held unchanged its position in AGYS. The position peaked in Q2 2026 at 552.56K shares.
Which other funds hold AGYS?
Other major institutional holders of AGYS include MAK CAPITAL ONE LLC, GENEVA CAPITAL MANAGEMENT LLC, EMERALD ADVISERS, LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.